Approval · Notice of Compliance 2802 · 1998
PENTA-CAPTOPRIL TABLETS: Notice of Compliance 2802
Issued February 11, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2802
- Date
- February 11, 1998
- Company
- Pentapharm Ltd.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PENTA-CAPTOPRIL TABLETS | 02234254 | Cancelled (Unreturned Annual) |
| PENTA-CAPTOPRIL TABLETS | 02234255 | Cancelled (Unreturned Annual) |
| PENTA-CAPTOPRIL TABLETS | 02234256 | Cancelled (Unreturned Annual) |
| PENTA-CAPTOPRIL TABLETS | 02234257 | Cancelled (Unreturned Annual) |